NO331222B1 - Topisk hormonpreparat med systemisk effekt - Google Patents

Topisk hormonpreparat med systemisk effekt

Info

Publication number
NO331222B1
NO331222B1 NO20004745A NO20004745A NO331222B1 NO 331222 B1 NO331222 B1 NO 331222B1 NO 20004745 A NO20004745 A NO 20004745A NO 20004745 A NO20004745 A NO 20004745A NO 331222 B1 NO331222 B1 NO 331222B1
Authority
NO
Norway
Prior art keywords
systemic effect
hormone preparation
topical hormone
topical
preparation
Prior art date
Application number
NO20004745A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004745L (no
NO20004745D0 (no
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NO20004745D0 publication Critical patent/NO20004745D0/no
Publication of NO20004745L publication Critical patent/NO20004745L/no
Publication of NO331222B1 publication Critical patent/NO331222B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
NO20004745A 1998-03-23 2000-09-22 Topisk hormonpreparat med systemisk effekt NO331222B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803533A FR2776191B1 (fr) 1998-03-23 1998-03-23 Composition hormonale topique a effet systemique
PCT/FR1999/000680 WO1999048477A1 (fr) 1998-03-23 1999-03-23 Composition hormonale topique a effet systemique

Publications (3)

Publication Number Publication Date
NO20004745D0 NO20004745D0 (no) 2000-09-22
NO20004745L NO20004745L (no) 2000-11-20
NO331222B1 true NO331222B1 (no) 2011-11-07

Family

ID=9524367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004745A NO331222B1 (no) 1998-03-23 2000-09-22 Topisk hormonpreparat med systemisk effekt

Country Status (29)

Country Link
US (1) US20080227763A1 (ja)
EP (1) EP1066030B1 (ja)
JP (1) JP4579411B2 (ja)
KR (1) KR100681322B1 (ja)
CN (1) CN1161102C (ja)
AP (1) AP1343A (ja)
AT (1) ATE353626T1 (ja)
AU (1) AU754490B2 (ja)
BR (1) BR9909027A (ja)
CA (1) CA2324904C (ja)
CY (1) CY1106463T1 (ja)
CZ (1) CZ300484B6 (ja)
DE (1) DE69935135T2 (ja)
DK (1) DK1066030T3 (ja)
ES (1) ES2283106T3 (ja)
FR (1) FR2776191B1 (ja)
HK (1) HK1038184A1 (ja)
HU (1) HU228863B1 (ja)
ID (1) ID27988A (ja)
IL (1) IL138607A0 (ja)
NO (1) NO331222B1 (ja)
NZ (1) NZ507201A (ja)
OA (1) OA11489A (ja)
PL (1) PL204210B1 (ja)
PT (1) PT1066030E (ja)
RU (1) RU2215520C2 (ja)
TR (1) TR200002751T2 (ja)
WO (1) WO1999048477A1 (ja)
ZA (1) ZA200005785B (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2349203C (en) * 1998-11-20 2013-05-21 Rtp Pharma Inc. Dispersible phospholipid stabilized microparticles
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US7803392B2 (en) 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US7005557B2 (en) * 2001-07-03 2006-02-28 The Procter & Gamble Company Film-forming compositions for protecting skin from body fluids and articles made therefrom
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
DE10146541A1 (de) * 2001-09-21 2003-04-17 Kade Pharma Fab Gmbh Arzneimittel auf Basis von Gestagenen zur dermalen Anwendung
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US7772213B2 (en) 2006-07-27 2010-08-10 Nathan Strick Composition for the treatment of inflammatory conditions
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2742932A1 (en) * 2012-12-17 2014-06-18 Laboratorios Ojer Pharma S.L. Gel compositions
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
MX2016013693A (es) 2014-07-29 2017-10-31 Therapeuticsmd Inc Crema transdermica.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
WO2020161771A1 (ja) * 2019-02-04 2020-08-13 マルホ株式会社 皮膚用組成物
GB2597637A (en) * 2020-06-02 2022-02-09 Surfachem Ltd Sanitiser composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018570A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Therapeutically effective topical application of st1435
FR2668945B1 (fr) * 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
JPH05148146A (ja) * 1991-06-20 1993-06-15 Terumo Corp 水溶性ゲル外用剤
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
IL105600A (en) * 1993-05-04 1999-12-31 Allon Blank Pharmaceutical and cosmetic compositions with increased rate of transdermal penetration and antioxidation protection against degradation containing derivatives of thioglycolic and mercaptopropionic acids some such novel compounds and their use
EP0785211A1 (en) * 1996-01-22 1997-07-23 Laboratoire Theramex New substituted 19-nor-pregnane derivatives
EP0785212A1 (en) * 1996-01-22 1997-07-23 Laboratoire Theramex New 19-nor-pregnene derivatives
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
IT1283102B1 (it) * 1996-06-06 1998-04-07 Permatec Nv Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele

Also Published As

Publication number Publication date
EP1066030B1 (fr) 2007-02-14
HUP0101579A2 (hu) 2001-11-28
PL204210B1 (pl) 2009-12-31
CZ300484B6 (cs) 2009-05-27
PT1066030E (pt) 2007-05-31
CZ20003471A3 (cs) 2001-07-11
CA2324904A1 (fr) 1999-09-30
IL138607A0 (en) 2001-10-31
TR200002751T2 (tr) 2000-12-21
NO20004745L (no) 2000-11-20
HU228863B1 (en) 2013-06-28
BR9909027A (pt) 2001-12-11
KR100681322B1 (ko) 2007-02-09
AP2000001948A0 (en) 2000-12-31
DK1066030T3 (da) 2007-06-11
JP4579411B2 (ja) 2010-11-10
HUP0101579A3 (en) 2002-01-28
CY1106463T1 (el) 2012-01-25
EP1066030A1 (fr) 2001-01-10
AP1343A (en) 2004-12-15
OA11489A (fr) 2004-05-08
NZ507201A (en) 2003-07-25
DE69935135T2 (de) 2007-10-31
DE69935135D1 (de) 2007-03-29
ID27988A (id) 2001-05-03
ES2283106T3 (es) 2007-10-16
PL343256A1 (en) 2001-07-30
KR20010042152A (ko) 2001-05-25
WO1999048477A1 (fr) 1999-09-30
AU754490B2 (en) 2002-11-21
JP2002507561A (ja) 2002-03-12
HK1038184A1 (en) 2002-03-08
NO20004745D0 (no) 2000-09-22
RU2215520C2 (ru) 2003-11-10
ZA200005785B (en) 2001-06-12
CN1161102C (zh) 2004-08-11
CA2324904C (fr) 2009-03-03
FR2776191A1 (fr) 1999-09-24
FR2776191B1 (fr) 2002-05-31
US20080227763A1 (en) 2008-09-18
CN1301146A (zh) 2001-06-27
AU2845199A (en) 1999-10-18
ATE353626T1 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
NO331222B1 (no) Topisk hormonpreparat med systemisk effekt
DE60022162D1 (de) Topische zusammensetzung mit n-acetylglukosamin
HUP0204349A3 (en) Novel topical oestroprogestational compositions with systemic effect
FI20001826A (fi) Yksitasoinen kaksinauha-antenni
DK1071420T3 (da) Indolyl-3-glyoxylsyrederivater med antitumorvirkning
ATE308319T1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
EP1073401A4 (en) TOPICAL ANESTHETIC COMPOSITION
PL345535A1 (en) Topical plaster with non-steroidal antirheumatic agents with an acid group
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
DE59910140D1 (de) Gleitschalungsfertiger
ID27776A (id) Bahan dengan efek antidepresan
NO20011514L (no) Antenneanordning med mikrostrimmelantennepar
NO20020151D0 (no) Veksthormonformuleringer
DE69904255D1 (de) Dosiervorrichtung
NO20013015D0 (no) Liposominfluminsyre - ny transdermal antiinflammatorisk medisin
DK1230369T3 (da) Polypeptidhormon phosphatonin
DE69934804D1 (de) Supraleiter
NO307950B1 (no) Forbedret IN-struktur med ADSI-server
GB9819994D0 (en) Topical preparation
DE69900704D1 (de) Dosiervorrichtung
ITCE970002U1 (it) Nifedipina per uso topico
FI19992584A (fi) Voidemainen koostumus
GB9811542D0 (en) Topical composition
HU0002800D0 (en) Topical composition with analgetic effect
KR980000235U (ko) 고정구가 구비된 넥타이

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees